The epidermal growth factor receptor inhibitor gefitinib prevents the progression of pancreatic lesions to carcinoma in a conditional LSL-Kras G12D/+ transgenic mouse model

Altaf Mohammed, Naveena B. Janakiram, Qian Li, Venkateshwar Madka, Misty Ely, Stan Lightfoot, Howard Crawford, Vernon E. Steele, Chinthalapally V. Rao

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Fingerprint

Dive into the research topics of 'The epidermal growth factor receptor inhibitor gefitinib prevents the progression of pancreatic lesions to carcinoma in a conditional LSL-Kras G12D/+ transgenic mouse model'. Together they form a unique fingerprint.

Medicine & Life Sciences